The above results confirmed that LINC01419 catalyzes H3K27me3 in the RECK promoter region by binding to EZH2.LINC01419 thus partially inhibits the apparent expression of RECK and promotes growth and migration of HCC cells. The gene discussed is EZH2; the disease is hepatocellular carcinoma.